AzTrials
AzTrials

Edentulism in Lower JawEvaluationNCT07262307

Evaluation of PEEK Versus Titanium Bar Attachments With Implant Assisted Mandibular Complete Overdenture Fabricated by CAD/CAM Technology

A study testing implant overdenture in people with Edentulism in Lower Jaw, run by Tanta University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Evaluation of PEEK versus Titanium Bar Attachments with Implant Assisted Mandibular Complete Overdenture fabricated by CAD/CAM Technology measuring retention of the overdenture and implant evaluation for 6 months and one year Read more about this study

Who is it for?
Ages 45 to 60 years, men onlyHealthy volunteers can take part
Conditions the study is for
Edentulism in Lower Jaw
What is being tested?
implant overdenture
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteEgypt
Study dates
30 May 2024to 28 Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 60 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • • Completely edentulous patients free from systemic diseases that may affect soft or hard tissue healing.
  • Patient's age ranges from 40 to 60 years old.
  • The bone quality and quantity of the mandibular alveolar ridge must fulfill the criteria for implant placement.
  • They have normal class Ӏ maxilla-mandibular relationship and sufficient inter-arch space with at least 25mm for bar attachment.
  • They have good oral hygiene.

Who cannot join

  • Systemic disorders that may influence soft or hard tissue healing as oral diseases.
  • Patients with history of radiation therapy in the head and neck region.
  • Patients with neurological or psychological problems that may impair good oral hygiene.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry

    Tanta, Elgharbiy

Other trials in Egypt

About this study

Evaluation of PEEK versus Titanium Bar Attachments with Implant Assisted Mandibular Complete Overdenture fabricated by CAD/CAM Technology measuring retention of the overdenture and implant evaluation for 6 months and one year

Being tested
implant overdenture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • implant overdentureDevice

    using of CAD/CAM with new material and digital fabrication techniques

Study groups in NCT07262307
Study groupRoleWhat they receive
Evaluation of PEEK materialExperimentaldigital fabrications techniques
Receives: Device: implant overdenture
Group Ӏ (control group): Six patients will receive digital mandibular implant overdenture assisted bActive comparator• Clinical evaluation
Receives: Device: implant overdenture
PEEK group new materialExperimentalNot described
Receives: Device: implant overdenture
PEEK material study groupExperimentalNot described
Receives: Device: implant overdenture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. retention of mandibular overdenture

    Retention of the mandibular implant-assisted complete overdenture will be measured using a digital force meter. Measurements will be taken at 6 months and 12 months after denture insertion.

    Measured: 6 months and 12 months post-insertion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2025
  2. Study start30 May 2024
  3. Primary completion23 Apr 2026
  4. Study completion28 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07262307
Sponsor's protocol ID
2140
Acronym
Evaluation
Status last verified
Oct 2026
First submitted
7 Sep 2025
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing implant overdenture in people with Edentulism in Lower Jaw, run by Tanta University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

retention of mandibular overdenture (time frame: 6 months and 12 months post-insertion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in